Cowen raised its price target on Impax Laboratories (NASDAQ: IPXL) to $20.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Stocks with increasing unusual option volume: IPXL MYL PSTG JDAugust 9, 2017 9:46 AM Impax Laboratories (IPXL) Tops Q2 EPS by 4cAugust 9, 2017 7:08 AM Impax Reports Solid Second Quarter 2017 Results with Total Revenues Increasing 17% to $202 MillionAugust 9, 2017 7:00 AM Impax Laboratories (IPXL) Reports Settlement of Contract Litigation on Opana ER (Oxymorphone Hydrochloride) CII Extended-Release TabletsAugust 7, 2017 7:59 AM Impax Announces Settlement of Contract Litigation on Opana® ER (Oxymorphone Hydrochloride) CII Extended-Release TabletsAugust 7, 2017 7:30 AM